EUVIMEDEUVIMED entdecken
Crossref

Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry

Rémi Diesler iD, Ségolène Turquier, Martine Reynaud-Gaubert, François Lestelle, Thomas Lacoste-Palasset, Victor Valentin iD, Sébastien Quétant, Ari Chaouat iD, Clément Boissin, Élise Noël-Savina, Cécile Tromeur, Aurélien Justet und 29 weitere

European Respiratory Journal · 2026-08 · 68 (2) · 2502233

DOI: 10.1183/13993003.02233-2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 26.03.2026. Verfasst von Rémi Diesler und 40 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Centre for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, ERN-LUNG, UMR 754, INRAE, Claude Bernard Unive…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Lung Diseases, Interstitial. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Programme Hospitalier de Recherche Clinique.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary hypertension (PH) frequently complicates interstitial lung diseases (ILDs), adversely affecting outcome. Identifying prognostic factors of patients with PH associated with ILD (ILD-PH) could facilitate early identification of patients who may benefit from PH therapy.

Methods

We included patients with ILD-PH from the prospective HYPID cohort and the French National Pulmonary Hypertension Registry (2007–2022). Univariable and multivariable analyses were performed to identify predictors of 1-year mortality.

Results

A total of 581 patients (mean age 69.4±9.3 years; 450 males) were analysed. ILD diagnoses were combined pulmonary fibrosis and emphysema (CPFE) syndrome (30.8%), idiopathic pulmonary fibrosis (29.6%), unclassifiable ILD (13.1%) and fibrotic hypersensitivity pneumonitis (10.3%). Mean pulmonary arterial pressure was 40.7±9.1 mmHg and mean pulmonary vascular resistance (PVR) was 7.6±3.5 Wood units (WU). Off-label PH therapy was initiated after initial evaluation in 215 patients (37%). The median transplant-free survival time was 17 (95% CI 15.2–not reached) months. Multivariable analysis identified male sex (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryLung Diseases, InterstitialHumansMaleFemaleAgedRegistriesPrognosisFranceMiddle AgedProspective StudiesIdiopathic Pulmonary FibrosisVascular Resistance

Autor:innen und Institutionen

  • National Reference Centre for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, ERN-LUNG, UMR 754, INRAE, Claude Bernard University Lyon 1, Lyon, France.
  • Constitutive Reference Center for Pulmonary Hypertension, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France.
  • Department of Respiratory Medicine and Lung Transplantation, North University Hospital, AP-HM, C2VN - INSERM1263 - INRAE1260, Aix Marseille University, Marseille, France.
  • Université Paris-Saclay, Inserm UMR_S 999 (HPPIT), Department of Respiratory and Intensive Care Medicine (FHU André Cournand, ERN-LUNG), Hôpital Bicêtre (AP-HP), Le Kremlin-Bicêtre, France.
  • Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Centre de Référence Constitutif des Maladies Pulmonaires Rares OrphaLung, Lille…
  • Université Grenoble Alpes, Service Hospitalo-Universitaire de Pneumologie-Physiologie, CHU Grenoble Alpes, Grenoble, France.

ORCID-Profile: Rémi Diesler, Victor Valentin, Ari Chaouat, Laurent Bertoletti, Fréderic Gagnadoux, Olivier Sitbon, Bruno Degano, Simon Valentin, Arnaud Bourdin, Marc Humbert, Athénaïs Boucly, David Montani, Vincent Cottin

Förderung

  • Programme Hospitalier de Recherche Clinique

Zitieren

APA

Diesler, R., Turquier, S., Reynaud-Gaubert, M., Lestelle, F., Lacoste-Palasset, T., Valentin, V., Quétant, S., Chaouat, A., Boissin, C., Noël-Savina, É., Tromeur, C., Justet, A., Maurac, A., Artaud-Macari, É., Nunes, H., Bertoletti, L., Magro, P., Horeau-Langlard, D., Seronde, M. F., …, & PulmoTension and OrphaLung networks (2026). Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry. European Respiratory Journal, 68(2), 2502233. https://doi.org/10.1183/13993003.02233-2025

Vancouver

Diesler R, Turquier S, Reynaud-Gaubert M, Lestelle F, Lacoste-Palasset T, Valentin V, et al. Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry. European Respiratory Journal. 2026;68(2):2502233. doi:10.1183/13993003.02233-2025

BibTeX
@article{Diesler2026,
  author = {Diesler, Rémi and Turquier, Ségolène and Reynaud-Gaubert, Martine and Lestelle, François and Lacoste-Palasset, Thomas and Valentin, Victor and Quétant, Sébastien and Chaouat, Ari and Boissin, Clément and Noël-Savina, Élise and Tromeur, Cécile and Justet, Aurélien and Maurac, Arnaud and Artaud-Macari, Élise and Nunes, Hilario and Bertoletti, Laurent and Magro, Pascal and Horeau-Langlard, Delphine and Seronde, Marie-France and Favrolt, Nicolas and Trésorier, Romain and Lamia, Bouchra and Chabanne, Céline and Riou, Marianne and Renard, Sébastien and Sanchez, Olivier and Gagnadoux, Fréderic and Nieves, Ana and Ahmad, Kais and Traclet, Julie and Sitbon, Olivier and Lamblin, Nicolas and Degano, Bruno and Valentin, Simon and Bourdin, Arnaud and Humbert, Marc and Boucly, Athénaïs and Subtil, Fabien and Montani, David and Cottin, Vincent and PulmoTension and OrphaLung networks, PulmoTension and OrphaLung networks},
  title = {Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry},
  journal = {European Respiratory Journal},
  year = {2026},
  volume = {68},
  number = {2},
  pages = {2502233},
  doi = {10.1183/13993003.02233-2025}
}
Kostenlos starten →